At Center for Breakthrough Medicines, our mission is to save lives by accelerating the development and manufacturing of advanced therapies.
Our fully integrated services include drug substance and drug product for all phases of the product lifecycle at a single site.
The Center for Breakthrough Medicines (CBM), a contract development, and manufacturing organization (CDMO) has launched their plasmid manufacturing offering, Precision PlasmidsTM to provide phase-appropriate plasmid on-demand to accelerate the path to clinic for cell and gene therapies.February 2, 2023
Center for Breakthrough Medicines Amplifies Viral Vector Manufacturing Capabilities by Licensing Asimov’s High-Performance GMP Suspension HEK293 PlatformJanuary 18, 2023
Autolomous LTD, the market-leading developer of critical manufacturing management systems for Cell and Gene Therapies (CGT), today announced a license agreement with U.S.-based Center for Breakthrough Medicines (CBM) a cell and gene therapy contract development, manufacturing, and testing organization (CDMO).January 12, 2023
End-to-End Manufacturing at a Single Site and High-throughput Vector Suite Design Will Bolster Batch Production Up to Five TimesDecember 8, 2022
The Center for Breakthrough Medicines (CBM), announced today the launch of their Analytical AcceleratorTM for AAV Testing to help gene therapy developers meet the quality domains of identity, safety, purity, potency, and stability required by the Food and Drug Administration (FDA) and global regulatory authorities.October 19, 2022
Our empowering culture supports people committed to transforming patients’ lives.Learn More >
CBM is led by an amazing team. Discover the caliber of people you will work with.Learn more >